IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q2 2024 Holdings

Filed 2024-08-14 | 12 holdings | $19.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Xeris Biopharma Holdings Inc(XERS)COM98422E103$11.5M5,113,34858.3%
Rezolute Inc(RZLT)COM NEW76200L309$5.7M1,318,96728.7%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$1.0M1,8695.2%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$417.1K1,0252.1%
Lexeo Therapeutics Inc(LXEO)COM52886X107$286.3K17,8511.5%
Mind Medicine Inc(BRD1EUR)COM NEW60255C885$219.1K30,3831.1%
Abivax SA(ABVX)SPONSORED ADS00370M103$183.8K13,9000.9%
Kyverna Therapeutics Inc(KYTX)COM501976104$172.4K22,9810.9%
Molecular Templates IncCOM NEW608550208$157.4K136,8660.8%
Compass Therapeutics Inc(CMPX)COM20454B104$43.5K43,4650.2%
Context Therapeutics Inc(CNTX)COM21077P108$36.9K18,4030.2%
Adicet BIO Inc(TORCEUR)COM007002108$21.2K17,4880.1%